| Literature DB >> 34408719 |
Rory J Piper1,2,3, Chayanin Tangwiriyasakul4,5, Elhum A Shamshiri6,7,8, Maria Centeno9, Xiaosong He10, Mark P Richardson4, Martin M Tisdall2, David W Carmichael3.
Abstract
Objective: Whilst stimulation of the anterior nucleus of the thalamus has shown efficacy for reducing seizure frequency in adults, alterations in thalamic connectivity have not been explored in children. We tested the hypotheses that (a) the anterior thalamus has increased functional connectivity in children with focal epilepsy, and (b) this alteration in the connectome is a persistent effect of the disease rather than due to transient epileptiform activity.Entities:
Keywords: childhood epilepsies; connectivity; deep brain stimulation; electroencephaloagraphy; epilepsy; focal epilepsies; functional magnetic resonance imaging; thalamus
Year: 2021 PMID: 34408719 PMCID: PMC8365837 DOI: 10.3389/fneur.2021.670881
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Imaging analysis pipeline. (A) Pre-processing pipeline. (B) Timeseries extraction. (C) Demonstration of the correction method for interictal epileptiform discharges (IEDs) in the anterior nucleus of the thalamus for patients 13 (one spike type) as detailed in Table 1. (D) Functional network analysis.
Demographic, clinical, neurophysiological, and neuroradiological descriptions of each child.
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| 1 | 8 | Female | Left | Temporal | Tuberous sclerosis | Focal | 2 | NZP and ZNS | |
| 2 | 14 | 4 | Female | Left | Frontal | Cryptogenic | Focal | 2 | LCM and LVT |
| 3 | 11 | 0.25 | Male | Left | Hypothalamus/temporal | Hypothalamic hamartoma | Focal | 59 | LVT |
| 4 | 15 | 10 | Male | Left | Posterior quadrant | Cryptogenic | Multifocal | 31, 10 | CBZ |
| 5 | 17 | Male | Right | Parietal | Focal cortical dysplasia | Multifocal | 51, 37, 71, 28 | LVT, CBZ, and VPA | |
| 6 | 15 | 10 | Male | Right | Frontal-central | Cryptogenic | Focal | 15 | CBZ |
| 7 | 17 | 3 | Female | Left | Temporal | Cryptogenic | Multifocal | 175, 30, 131 | LVT |
| 8 | 14 | 2.5 | Female | Right | Temporal | Focal cortical dysplasia | Multifocal | 206, 16 | LVT and TOP |
| 9 | 11 | 6 | Female | Right | Frontal-temporal | Cryptogenic | Focal | 132 | CBZ and LTG |
| 10 | 11 | 7 | Female | Right | Frontal | Focal cortical dysplasia | Focal | 141 | OXC |
| 11 | 17 | 10 | Female | Right | Frontal | Cryptogenic | Focal | 34 | LTG and LEV |
| 12 | 16 | 6 | Female | Left | Frontal | Cryptogenic | Focal | 7 | VPA and CBZ |
| 13 | 16 | 13 | Female | Left | Insula | Focal cortical dysplasia | Focal | 76 | TPM and CBZ |
| 14 | 11 | 3 | Male | Right | Frontal | Cryptogenic | Multifocal | 128, 29 | CBZ |
| 15 | 11 | 8 | Male | Right | Frontal | Cryptogenic | Multifocal | 25, 1 | LVT and VPA |
| 16 | 16 | 2 | Female | Left | Temporal-parietal-occipital | Polymicrogyria | Multifocal | 236, 62, 39 | LEV and CLNZ |
| 17 | 15 | 9 | Male | Left | Temporo-occipital | Hippocampal sclerosis | Multifocal | 83, 21 | LMT 575 Zonasimne 200 |
| 18 | 15 | 8 | Male | Left | Fronto-temporal | Focal cortical dysplasia | Focal | 112 | OXZC 1200 LVT |
| 19 | 17 | 5 | Female | Left | Frontal | Cryptogenic | Focal | 82 | OXC |
| 20 | 8 | 4 | Female | Left | Frontal | Middle cerebral artery stroke | Focal | 150 | VPA 1200, LEV 600, ETHX 1000 |
| 21 | 16 | Male | Left | Frontal | Cryptogenic | Multifocal | 129, 77 | PMP | |
| 22 | 13 | 3 | Male | Left | Frontal | Focal cortical dysplasia | Focal | 26 | OXC and CLBZ |
| 23 | 10 | 3 | Female | Left | Frontal | Cryptogenic | Multifocal | 47, 4 | LVT and CBZ |
| 24 | 11 | 6 | Male | Right | Posterior quadrant | Cryptogenic | Multifocal | 25, 23, 5 | OXC |
| 25 | 17 | 8 | Male | Left | Frontal | Cryptogenic | Multifocal | 35, 13 | LVT, OXC, and CLBZ |
| 26 | 17 | Male | Right | Occipital | Ischaemic perinatal insult | Focal | 21 | OXC, LMT, and LVT 2000 | |
| 27 | 18 | Female | Right | Frontal | Focal cortical dysplasia | Multifocal | 148, 6 | LTG | |
| 28 | 17 | 5 | Female | Right | Fronto-temporal | Bilateral polymicrogyria | Multifocal | 242, 43 | LVT and VPA |
| 29 | 11 | Female | Right | Parietal | Cryptogenic | Focal | 81 | OXC, PHE, and CLBZ | |
| 30 | 17 | 5 | Male | Left | Frontal | Cryptogenic | Focal | 67 | LVT and LAC |
| 31 | 11 | 5 | Female | Right | Parietal | Focal cortical dysplasia | Focal | 450 | OXC, CLBZ, and VPA |
| 32 | 17 | 12 | Female | Left | Frontal | Cryptogenic | Multifocal | 62, 1, 75 | VPA |
| 33 | 13 | 7 | Female | Left | Frontal | Focal cortical dysplasia | Multifocal | 128, 23 | VPA |
| 34 | 15 | Female | Right | Posterior cingulate | Dysembryoplastic neuroepithelial tumor | Focal | 26 | LVT and LTG | |
| 35 | 7 | Male | Left | Frontal | Cryptogenic | Focal | 145 | LVT, OXC, and CLBZ |
The number of interictal epileptiform discharges (IEDs) are listed for each IED type within each patient. EZ, epileptogenic zone; IED, interictal epileptiform discharge;
Age rounded to nearest integer.
Age-of-onset (if known) is an approximate. CBZ, Carbamazepine; CLBZ, Clobazam; GAB, Gabapentin; LCM, Lacosamide; LTG, Lamotrigine; LVT, Levetiracetam; NZP, nitrazepam; OXC, Oxcarbazepine; PHE, Phenobarbital; PGB, Pregabalin; PMP, Perampanel; RUF, Rufinamide; TPM, Topiramate; VPA, Valproate; ZNS, Zonisamide.
Summaries of the patient and control cohorts.
|
|
| |
|---|---|---|
| Median age (range) | 15 (7–18) years | 10 (7–17) years |
| Male:female ratio | 15:20 | 7:13 |
| Median age of seizure onset (range) | 6 (0.25–13) years | – |
| Median duration of epilepsy | 7 (3–14) years | – |
Data missing for eight patients.
Figure 2Degree centrality of the anterior thalamic subregion ipsilateral to the epileptogenic zone (EZ). The lines represent controls (blue), patients before (red) and after (green) correction for interictal epileptiform discharges (IEDs). The left graphs show the full range of network densities from 0 to 100%. The dotted box shows the range selected for statistical analysis and shown in the right graph.
Figure 3Area under the curve (AUC) for the degree centrality of the anterior thalamic subregion ipsilateral to the epileptogenic zone (EZ). The violin plot (28) demonstrates the distributions of the AUC for degree centrality in patients before (red) and after (green) interictal epileptiform discharges (IEDs) and controls (blue). The clear dot shows the median.